论文部分内容阅读
对于头颈部中晚期鳞癌患者，目前常规采用手术和或放疗的治疗方案。其中5 年存活率在20%50%间绯徊[ 1-6]， 预后较差，观察发现失败与远处转移相关。70 年代以来顺铂PDD 为主的联合化疗已成为头颈部鳞癌患者手术和或放疗前的辅助治疗方案之一，大剂量PDD 加5 Fu120h 连续滴注化
For patients with advanced squamous cell carcinoma of the head and neck, surgical and/or radiotherapy regimens are routinely used. The 5-year survival rate was between 20% and 50% [1-6]. The prognosis was poor. Observe that the failure was related to distant metastasis. Since the 1970s, cisplatin-based PDD-based combination chemotherapy has become one of the adjuvant treatment options for patients with head and neck squamous cell carcinoma before surgery and/or radiotherapy. High-dose PDD plus 5 Fu120h continuous infusion